Tag: Biotechnologies

Biotechnology is the use of living systems and organisms to develop or make products, or “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use”. Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, biomanufacturing, molecular engineering, etc.

Ferring Pharmaceuticals will launch a new biotech centre in Switzerland

ferring
Ferring Pharmaceuticals is expanding its capabilities in biologics through a new biotech centre which will be installed at the company’s existing headquarters and manufacturing site in Saint-Prex, Switzerland.

International investors will keep an eye on Armenian biotech startups

flag of armenia
More than a dozen of sponsors will invest in Armenian IT and science startups. The informal network of science and technology investors united 18 businessmen from the US, UK, Russia and Cyprus.

A project on biopharmaceutical research center is discussed in Novosibirsk

biotechnology
Novosibirsk region may become one of the leading federal centers for development of science and engineering in the area of biotechnology to attract investments in biotech

Pall Corporation sets up a new biotechnology unit

test tubes
Pall Corporation, a global leader in filtration, separation and purification, has a newly named business unit within the Pall Life Sciences division

Cannabinoid-based epilepsy drug from GW Pharmaceuticals shows promising results

medicinal cannabis
GW Pharmaceuticals, a biopharmaceutical company focused on developing novel therapeutics from its proprietary cannabinoid product platform, announced that The Lancet has published results from a Phase 3 study of Epidiolex

Abcam announced an exclusive licensing deal with Roche

biotechnology
Abcam, a global leader in the supply of life science research tools, announced that it has entered into a definitive license agreement with Roche

CBMG boosts its cell therapy manufacturing

biotech
Cellular Biomedicine Group Inc., a leading clinical-stage biopharmaceutical firm, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory platform

Croda announces the acquisition of Nautilus Biosciences Canada

croda
Croda International Plc, a British speciality chemicals company, announced that it has acquired Nautilus Biosciences Canada Inc, a technology-rich marine biotechnology company

GenCure launches BioManufacturing Centre for production of stem cells

stem cells
GenCure opened the first phase of a new biomanufacturing center designed to address a critical roadblock slowing the advancement of cellular therapies

Evotec and APEIRON reached the first landmark in their alliance with Sanofi

research lab
Evotec AG and APEIRON Biologics AG announced that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015

Major changes for bio supply forecast in 2018 by bioLIVE

Integration of supply chain a critical issue as industry globalises, with a resurgence in European manufacturing and biotech markets forecast

WuXi Biologics put its new cGMP manufacturing facility into service

biotech
WuXi Biologicsannounced that its cGMP biologics manufacturing facility in Wuxi city with 30000 L bioreactor capacity entered into full operation

Dutch biotech company launches its ultra fast PCR in France and Switzerland

pcr
Molecular Biology Systems announced it will launch its revolutionary NEXTGENPCR through AMPLITECH in France, Belgium, Luxembourg, and Switzerland

Sphere Fluidics and Geneva Biotech received Eurostars grant

dna genome
Sphere Fluidics and Geneva Biotech have received a €1.6 million grant from Eurostars

BioMed X and Boehringer Ingelheim initiated new joint research group

biotechnology
BioMed X announced the start of a new joint research group with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg

Chemo Group changes its name to INSUD PHARMA

pills
Chemo Group, the pharmaceutical multinational that is present in over 40 countries, announced it is going to be called INSUD PHARMA